Last reviewed · How we verify

COVID19 mRNA vaccine — Competitive Intelligence Brief

COVID19 mRNA vaccine (COVID19 mRNA vaccine) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Area: Immunology.

phase 2 Immunology Biologic Live · refreshed every 30 min

Target snapshot

COVID19 mRNA vaccine (COVID19 mRNA vaccine) — Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico. The COVID19 mRNA vaccine works by instructing cells to produce a piece of a viral protein, triggering an immune response to the virus.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
COVID19 mRNA vaccine TARGET COVID19 mRNA vaccine Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico phase 2

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). COVID19 mRNA vaccine — Competitive Intelligence Brief. https://druglandscape.com/ci/covid19-mrna-vaccine. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators: